Clinical trial
Natural History Study of Retinitis Pigmentosa Due to RHO, PDE6a or PDE6b Mutations
NCT04285398 is registered in ClinicalTrials.gov with SparingVision as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Natural History Study of Retinitis Pigmentosa Due to RHO, PDE6a or PDE6b Mutations
- Lead sponsor
- SparingVision
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 12, 2020
- Completion date
- June 30, 2026
- Enrollment
- 82 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.